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Breast-conserving therapy (BCT) is accepted as effective as mastec-
tomy in treating early breast cancer. In June 1990, a Consensus
Development Conference of the US National Institutes of Health
concluded that breast conservation was appropriate for most women
with Stage I and II breast cancer and was preferable to total mastec-
tomy because it provided equivalent survival while preserving the
breast (National Institute of Health, 1990). This position has been
taken in other national and professional guidelines (National Health
& Medical Research Council, 1995; Haward et al, 1999). 
Changing established patterns of practice in areas such as clin-
ical management of breast cancer usually takes time (Haward et al,
1999). Nonetheless, the release of information about treatment
from clinical trials of the 1980s and the consensus statements that
followed are widely credited with an increased uptake of BCT
in the mid-to late 1980s and early 1990s in Europe and USA.
Population-based reports on trends in breast cancer treatment,
however, have been few in number (de Koning et al, 1994), mainly
from the US SEER (Nattinger et al, 1996; Nattinger et al, 2000)
and Yorkshire registries (Haward et al, 1999). Nationwide treat-
ment data were available in the Netherlands, but not breast cancer
registrations (de Koning et al, 1994). 
Examination of population-based trends in breast cancer treat-
ment depends on population-based cancer registration and recording
of treatment. A minority of registries, however, such as the SEER
(Lazovich et al, 1997; Nattinger et al, 2000) and some UK registries
(Haward et al, 1999) collect treatment data, usually by sending
trained abstractors to local hospitals. In its absence, and hoc or
continuing linkage of routinely collected hospital inpatient records
with cancer registry records is a potentially workable alternative to
meet needs for population-based monitoring (Hobbs and McCall,
1970; Baldwin, 1972; Kahn et al, 1996; McGeechan et al, 1998). 
We used linked cancer registry records and inpatient records of
surgical management in New South Wales (NSW), the most popu-
lous Australian state, to examine changes in treatment for breast
cancer in Australia between 1992 and 1995. Specifically, we sought
to use these records to examine whether management practice had
changed to greater uptake of breast conservation surgery and, if so,
to study demographic and clinical correlates of the changes. 
SUBJECTS AND METHODS 
All cases of invasive breast cancer in women registered with breast
cancer in the population-based NSW Central Cancer Registry in
1992 and 1995 were eligible for this study. The NSW Department
of Health had linked Cancer Registry records of women diagnosed
with breast cancer in 1992 and 1995 with their NSW Inpatient
Statistics Collection (ISC) records for separations from any public
or private hospital up to 1 year before and 18 months after their
diagnosis. Linkage was probabilistic, using Automatch software,
and matched records by date of birth, hospital code, patient’s
medical record number, country of birth and address of residence;
the women’s names were not used. 
ICD9–CM procedure codes in the ISC records were used to clas-
sify each woman into one of five groups: mastectomy (ICD9–CM
85.41–85.48), breast conserving therapy (85.20–85.23), breast
conserving therapy and mastectomy, diagnostic breast procedures
only (85.0, 85.11, 85.12, 85.19), and no breast procedure. Analyses
of therapeutic surgical procedures used two categories, women
who had mastectomy (with or without BCT) and those who had
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BCT only. Separate analyses examined use of axillary surgery.
Women were considered to have had axillary surgery when there
was a code for axillary surgery (ICD9–CM 40.22, 40.23, 40.29,
40.3, 40.51) or for surgery to the lymph nodes with mastectomy
(85.43–85.48). Hospital admissions for surgery were counted up to
12 months after diagnosis. 
Age was analysed in broad age groups, country of birth in three
categories (Australia, UK and Europe, other countries) and resi-
dence at the admission closest to the date of diagnosis as urban or
rural according to a standard coding scheme. Area of residence was
used to categorize the women into one of five socio-economic
(SES) groups based on an index of relative socio-economic disad-
vantage for local government areas (LGAs). The index, derived by
the Australian Bureau of Statistics from the 1991 and 1996
Australian Censuses, was used to rank LGAs and divide them into
five SES groups of approximately equal population size. Spread of
cancer at diagnosis was classified as localized to the breast,
invading adjacent tissue or regional lymph nodes or distant metas-
tases. Breast cancer size was available for women 40–69 years
for the whole of 1992 and for women of all ages in 6 months of
1995 (Kricker et al, 1999) and was grouped into four categories
(0.1–0.9 cm, 1.0–1.9 cm, 2.0–2.9 cm and 3.0+ cm). 
Hospitals were classified as urban or rural and private or
public, and also grouped into categories of ‘surgical volume’ by
use of their numbers of therapeutic surgical procedures for breast
cancer in 1992 and 1995. The categories used were low (1–10
procedures), intermediate (11–20 procedures) and high (21 +
procedures). 
Predictors of mastectomy and axillary surgery in 1992 and
1995 were examined separately in logistic regression models,
initially within subsets of variables relating to the woman (age,
place of residence, SES of area of residence and country of
birth), the cancer (histopathological type, extent of disease, and
cancer size in women 40–69 years of age) and the hospital
(volume of surgery for breast cancer, urban or rural location and
public or private status). Variables that were independent predic-
tors of the procedure of interest within each subset in either year
were examined together in separate models for 1992 and 1995. 
RESULTS 
Most of the Cancer Registry records of women with invasive breast
cancer were successfully linked to ISC records in 1992 (93%) and
1995 (96%). All analyses were based on the linked records. 
Breast surgery 
Hospital admissions for BCT or mastectomy were recorded for
2020 women in 1992 and 2883 in 1995. A mastectomy was done
within 12 months of diagnosis in 61% of women in 1992 and 55%
in 1995. Breast conservation as the only surgical procedure
increased from 39% in 1992 to 45% in 1995. 
Urban women were less likely to have mastectomy than rural
women (Table 1) and this gap did not change between 1992 and
1995 (Tables 1 and 4). 
In 1992, women 80 years of age and older (OR 0.6, 95% CI
0.4–0.8) and 40–49 years (OR 0.8, 95% CI 0.6–1.0) were less
likely to have mastectomy than women 50–59 years (baseline age
group; P for heterogeneity with age 0.02; Table 2). Women 25–39
and 60–79 years had similar odds of mastectomy to women 50–59
years. In 1995 the odds for mastectomy varied less and were not
significantly heterogeneous by age (P = 0.3, Table 2). 
Analyses of the relationship between breast cancer size and
mastectomy were restricted to women 40–69 years of age for
whom cancer size was known (Table 3). Mastectomy increased
with increasing cancer size in urban women in both 1992 and
1995. The pattern in rural women was less clear, except that the
greatest use of mastectomy was in women with the largest (3+ cm)
cancers. The percentage of women with 3+ cm cancers who had
mastectomy changed little between 1992 and 1995. On the other
hand, the percentage who had mastectomy for <1 cm cancers fell
from 50% to 36% in urban women and 64% to 47% in rural
women. Most of the shift from mastectomy to BCT in this period
occurred in these smallest cancers. 
The odds of mastectomy were two-fold higher in the presence
of regional spread of cancer at diagnosis than with localized cancer
(Table 4). It was not increased in those with distant spread.
Table 1 Numbers of urban and rural women who had surgery and percentages of urban and rural women who had
mastectomy or breast conservation and axillary surgery for breast cancer in 1992 and 1995 by age group 
Urban women Rural women 
Age group Mastec- BCT Axillary No. of Mastec- BCT Axillary No. of 
tomy only surgery women tomy only surgery women 
%%% n %%% n
1992
<40 60 40 87 125 75 25 91 32 
40–49 55 45 82 371 68 32 87 108 
50–59 62 38 83 349 66 34 82 91 
60–69 63 37 81 320 65 35 75 124 
70–79 61 39 70 264 73 27 78 95 
80+ 46 54 46 111 57 43 57 30 
All ages 59 41 78 1540 67 33 80 480 
1995
<40 56 44 89 165 66 34 97 38 
40–49 57 43 89 461 56 44 92 130 
50–59 52 48 87 547 61 39 85 192 
60–69 51 49 81 479 59 41 82 164 
70–79 54 46 73 369 69 31 80 142 
80+ 49 51 52 128 56 44 44 68 
All ages 53 47 82 2149 61 39 81 734 
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Lobular cancer, although significantly associated with mastectomy
after adjustment for size and spread of cancer at diagnosis in 1992
(OR 1.7. 95% CI 1.1–2.7), was less strongly associated with it in
1995 (OR 1.3, 95% CI 0.8–2.1; Table 4). 
The odds of mastectomy did not vary significantly with socio-
economic status after adjustment for age and size and spread of
cancer at diagnosis (Table 4). Under similar conditions, mastec-
tomy was, if anything, most prevalent in hospitals in which
moderate numbers of breast procedures were done rather than in
those with few or many. 
Axillary surgery 
There were 1 580 women who had axillary surgery recorded in the
linked dataset in 1992 (78%) and 2,354 (82%) in 1995. Axillary
surgery was more often done in association with mastectomy (91%
in 1992, 93% in 1995) than with BCT (58% in 1992, 67% in 1995)
and increased between 1992 and 1995, mainly with BCT. 
Urban women were more likely to have axillary surgery with
BCT than rural women in 1992 and 1995 (Table 1) while the odds
of axillary surgery fell nearly 10-fold with increasing age (P-value
for age <0.001 in each year; Table 2). 
In comparison with cancers <1.0 cm in diameter, the odds of axil-
lary surgery in 1992 was significantly higher only for breast cancers
larger than 2 cm (OR for 2–2.9 cm = 1.8 95% CI 1.0–3.3; OR for 3+
cm = 1.6 95% CI 0.9–3.1) in women 40–69 years of age (Table 5). In
1995, it was some two-fold or more higher for all cancers 1 cm or
more in diameter in comparison with those <1.0 cm; the highest
odds ratio was in 2.0–2.9 cm cancers (OR = 3.3 95% CI 1.7–6.7). 
Regional spread of cancer at diagnosis was a strong predictor of
axillary surgery in 1992 (OR 2.4, 95% CI 1.6–3.7, with reference
to localized cancer) but not in 1995 (OR 1.5, 95% CI 0.9–2.6). 
Axillary surgery was much more likely in hospitals with moderate
or high numbers of breast procedures in 1992 than in those with low
numbers (Table 5). This difference was not present in 1995. 
DISCUSSION 
Breast conserving surgery increased in NSW between 1992 and
1995, mainly in women with small, localized breast cancers. For
larger breast cancers or cancers that had spread beyond the
breast, mastectomy remained the most common surgical treat-
ment. By 1995, most women had axillary surgery regardless of
cancer size or reported regional spread of the cancer. Women
Table 2 ORs for mastectomy and axillary surgery by age in women with invasive breast cancer in 1992 and 1995 
1992 1995 
Age ORa 95% CI ORa 95% CI 
Mastectomy 
24–39 0.99 0.68 1.45 1.13 0.82 1.55 
40–49 0.80 0.61 1.03 1.09 0.87 1.35 
50–59 1.00 1.00 
60–69 0.98 0.75 1.30 0.92 0.75 1.14 
70–79 1.02 0.76 1.37 1.16 0.92 1.46 
80+ 0.55 0.37 0.81 0.85 0.62 1.17 
P-value 0.02 P-value 0.3 
Axillary surgery 
24–39 1.48 0.86 2.55 1.52 0.90 2.55 
40–49 1.02 0.72 1.44 1.35 0.96 1.90 
50–59 1.00 1.00 
60–69 0.79 0.56 1.11 0.67 0.50 0.89 
70–79 0.52 0.37 0.73 0.46 0.35 0.62 
80+ 0.19 0.13 0.29 0.15 0.11 0.22 
P-value <0.001 P-value <0.001 
aORs were adjusted for urban or rural residence, SES and COB. 
Table 3 Size of breast cancer and type of surgical breast procedure by urban and rural place of residence in women 40–69 years
of age in 1992 and 1995 
1992 1995 
Urban Rural Urban Rural 
Mastec- BCT Mastec- BCT All Mastec- BCT Mastec- BCT All
tomy only tomy only women tomy only tomy only women 
n = 898 n = 271 n = 659 n = 200 
%% %% %%% %
Cancer size 
0–0.9 cm 50 50 70 30 128 36 64 53 47 160 
1–1.9 cm 49 51 55 45 455 50 50 53 47 386 
2.0–2.9 cm 62 38 63 37 329 64 36 50 50 206 
3.0+ cm 81 19 87 13 257 79 21 87 13 107 
All sizes 60 40 65 35 1169 54 46 58 43 859 
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with the smallest (<1 cm) cancers, however, were less likely to
have nodes removed. Axillary surgery fell steeply with
increasing age from 25–39 years to the oldest women 80+ years.
Our study depended on the linkage of two sets of routinely
collected, computerised health records, a well-regarded method
of enriching individually collected datasets for epidemiological
and health services research. 
BCT rates also increased in the USA and UK in the late 1980s
and early 1990s (Chouillet et al, 1994; Richards et al, 1996;
Nattinger et al, 1996; Lazovich et al, 1997) mainly, as in NSW, in
women with smaller cancers (Lazovich et al, 1997). In the USA,
rates of stage I cancers, which doubled from 1983 to 1996, were
already at a high level by 1990 (National Cancer Institute, 1999)
while BCT rates rose steadily from 1990 to 1995 (Lazovich et al,
1997; Nattinger et al, 2000). Thus, increasing BCT rates in the
1990s appear not to be due solely to increasing rates of smaller
cancers, though BCT rates in the USA were higher in women with
smaller cancers (Lazovich et al, 1997), as in NSW. 
BCT use appears to have peaked in the UK and Netherlands in
the late 1980s to 1990 at around 40% of women with breast cancer
(de Koning et al, 1994; Haward et al, 1999). The high rate in 1995
in NSW (45%) may prove to have been a peak and, if so, would be
consistent with De Koning et al’s (1994) predicted limit for BCT at
around 42% of all newly diagnosed breast cancers (de Koning 
et al, 1994). 
Mastectomy rates were higher in non-metropolitan than urban or
metropolitan women, as in the USA (Howe et al, 1992; Nattinger
et al, 1996; Lazovich et al, 1997), independently of any regional
differences in breast cancer size and stage at diagnosis (Table 4).
These higher rates were unlikely to be due to poorer health and a
consequent possible lower tolerance of adjuvant therapy since rural
Australian women, if anything, are healthier than urban women
(Mathers, 1994; Australian Institute of Health and Welfare, 1998).
Australian rural residents generally have a low use of medical
services and less access to specialist medical care (Australian
Institute of Health and Welfare, 1998) and their higher mastectomy
Table 4 Association of mastectomy with age, SES, urban or rural residence cancer spread, histopathological type,
cancer size, and the hospital volume of surgical procedures in women 40–69 years of age diagnosed with invasive
breast cancer in 1992 and 1995 
1992 1995 
(n = 1085) (n = 799) 
OR OR 
(adjusted) 95%CI (adjusted) 95%  CI 
Age (years) 
40–49 0.7 0.5 0.9 1.1 0.8 1.6 
50–59 1.0 1.00 
60–69 1.0 0.7 1.4 1.1 0.8 1.6 
P-value 0.01 P-value 0.7 
SES 
859–952 1.0 1.0 
953–979 0.6 0.4 1.0 0.8 0.5 1.3 
9810–1000 0.7 0.4 1.1 1.2 0.7 1.9 
1001–1057 0.8 0.5 1.2 1.1 0.7 1.8 
1058–1170 0.7 0.5 1.2 0.8 0.5 1.3 
P-value 0.4 P-value 0.5 
Residence 
Urban 1.0 1.0 
Rural 1.3 1.0 1.9 1.3 0.9 1.9 
P-value 0.09 P-value 0.3 
Extent of cancer 
Localized 1.0 1.0 
Regional 2.0 1.5 2.7 2.0 1.4 2.7 
Metastatic 0.8 0.3 2.3 1.1 0.2 6.8 
P-value <0.001 P-value <0.001 
Histopathological type 
Ductal 1.0 1.0 
Lobular 1.7 1.1 2.7 1.3 0.8 2.1 
Special types 0.7 0.4 1.1 0.5 0.3  1.0 
P-value 0.01 P-value 0.07 
Size (cm) 
0–0.9 1.0 1.0 
1.0–1.9 0.7 0.5 1.1 1.4 1.0 2.1 
2.0–2.9 1.1 0.7 1.7 1.8 1.1 2.9 
3+ 3.1 1.8 5.3 5.6 2.9 10.7 
P-value <0.001 P-value <0.001 
Hospital volume 
1–10 procedures 1.0 1.0 
11–20 procedures 1.5 0.9 2.6 1.3  0.6 2.5 
21+ procedures 0.9 0.6 1.4 1.3  0.7 2.1 
P-value 0.04 P-value 0.7 
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rates may have been due to less specialized care (Howe et al, 1992)
and less access to radiotherapy, a recommended accompaniment to
BCT (National Institute of Health 1990). 
Although we did not find that hospital caseload was a strong
predictor of BCT, higher surgeon caseload had been in a 1995
national survey (Hill et al, 1999) and low surgeon caseload a
predictor of mastectomy in urban NSW in 1992 (Taylor et al,
1999). Perhaps, as in the USA, use had become more uniform
across hospital settings by the 1990s (Lazovich et al, 1997). We
found little evidence that SES influenced BCT rates. 
Axillary surgery increased slightly from 1992 to a high
percentage of NSW women in 1995. The patterns of axillary
surgery mirrored US experience, accompanying mastectomy more
often than BCT and being inversely related to women’s ages and
only weakly related to cancer size (Du et al, 1999; Nattinger et al,
2000). Since larger cancer size predicts positive nodes and young
women have a higher probability of positive nodes than women of
other ages (Olivotto et al, 1998; Yiangou et al, 1999), axillary
surgery appeared to be appropriately targeted to younger women
but less evidently to larger breast cancers. 
If  ‘appropriate’ (arguably optimal) surgery is defined as
‘according to recommendation’, then just over 80% of women in
this study had optimal surgical treatment of the axilla. Axillary
dissection in early breast cancer aims to control disease by
reducing recurrence and to provide stage information for decisions
about systemic therapy. In addition, women place a high value on
knowing the status of the lymph nodes even when unfavourable,
despite poor outcomes in about 40% of women including arm
dysfunction such as pain and loss of grip strength (Galper et al,
2000). Attention, appropriately, to women’s preferences may
account for some of the 20% of women who appear not to have
optimal treatment of the axilla. 
Women also have personal reasons for choosing non-conserva-
tive surgery. Surgeons reported that 25% of Australian women
with early breast cancer in 1995 chose non-conservative surgery
for reasons such as concerns about recurrence or treatment by
radiotherapy, which were sometimes age- or residence-related
(Hill et al, 1999). This preference, together with those in relation to
axillary surgery, suggests that benchmarks should be set not only
for the proportions of women having particular procedures but also
for the proportions who were informed about the options and their
pros and cons, and whether their preferences were honoured. 
Our results show that detailed and informative analyses of
patterns of breast cancer care in a whole population can be gained
through linkage of routinely collected cancer registry and inpatient
statistics records when the cancer registry does not routinely
collect treatment data. This may be a cost-effective alternative to
separate collection of treatment data by cancer registries. 
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Table 5 Association of axillary surgery with age, SES, cancer spread, cancer size, and the hospital
volume of surgical procedures in women 40–69 years of age diagnosed with invasive breast cancer in
1992 and 1995 
1992 1995 
(n = 1088)  (n = 794) 
OR OR
(adjusted) 95% CI  (adjusted)  95% CI 
Age (years) 
40–49 1.0 0.7 1.6 0.9 0.5 1.7 
50–59 1.0 1.0 
60–69 0.9 0.6 1.4 0.5 0.3 0.9 
P-value 0.8 P-value 0.04 
SES 
859–952 1.0 1.0 
953–979 0.9 0.4 1.7 0.6 0.3 1.2 
980–1000 0.6 0.3 1.1 1.2 0.5 2.8 
1001–1057 1.3 0.6 2.6 0.6 0.3 1.3 
1058–1170 0.5 0.3 1.0 0.9 0.4 1.8 
P-value 0.008 P-value 0.2 
Extent of cancer 
Localized 1.0 1.00 
Regional 2.4 1.6 3.7 1.5 0.9 2.6 
Metastatic 0.7 0.2 2.3 –  ––  
P-value <0.001 P-value 0.1 
Size 
0–0.9 cm 1.0 1.0 
1.0–1.9 cm 1.0 0.6 1.8 2.2 1.3 3.8 
2.0–2.9 cm 1.8 1.0 3.3 3.3 1.7 6.7 
3+ cm 1.6 0.9 3.1 1.8 0.8 3.9 
P-value 0.04 P-value 0.003 
Hospital volume 
1–10 procedures 1.0 1.0 
11–20 procedures 2.0 1.1 3.6 1.1  0.4 3.1 
21+ procedures 2.6 1.6 4.1 1.1  0.5 2.5 
P-value <0.001 P-value 1.0 
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to the NSW Health Department, supplied the data on invasive
breast cancer in 1992 and 1995. The NSW Health Department
made available a linked file of surgical procedures recorded in the
NSW Inpatient Statistics Collection and women with breast cancer
registered by the Cancer Registry in 1992 and 1995. The National
Breast Cancer Centre is funded by the Commonwealth
Government of Australia. 
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